Recent Contracts
Active
Drugs and Pharmaceutical
CN4171505—Procurement of Imported Plasma and Recombinant Products (IPRP) – Hemlibra (emicizumab)$317.7M
30 June 2025 - 29 June 2028
Expired
Drugs and Pharmaceutical
CN3727716—Supply of Hemlibra$353.2M
31 Oct 2020 - 29 June 2025
Retender Opportunities
10 expiring contracts in this supplier's categories that may be retendered soon.
Unlock 10 retender opportunities
See contract values, current suppliers, and exact expiry dates.
Unlock opportunities →Peer Benchmarking
See how ROCHE PRODUCTS PTY LTD ranks against similar companies in their category and size band.
Unlock benchmarking →Financial Year Breakdown
FY25
$317.7M(1 contracts)
FY21
$353.2M(1 contracts)
Company Details
- Name
- ROCHE PRODUCTS PTY LTD
- Also known as
- Roche Foundation Medicine
- Entity Type
- Australian Private Company
- ABN
- 70 000 132 865
- ACN
- 000 132 865
- Status
- Registered
- Registered
- 3 June 1954
- Town/City
- Sydney
- Postcode
- 2000
- State/Territory
- NSW
- Country
- Australia